News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Hatice Bölek: Does treatment sequencing with cabazitaxel and 177Lu-PSMA-617 impact outcomes in mCRPC?
Hatice Bölek/X
Jan 10, 2025, 19:44

Hatice Bölek: Does treatment sequencing with cabazitaxel and 177Lu-PSMA-617 impact outcomes in mCRPC?

Hatice Bölek, Medical Oncologist at Ankara University School of Medicine, shared a recent article on X:

“Does treatment sequencing with cabazitaxel and 177Lu-PSMA-617 impact outcomes in mCRPC?

No difference in PFS2 and OS between treatment sequences.”

“Comparison of two alternative sequences with cabazitaxel and 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: A retrospective multicenter study (LuCaS)“

Authors: Hatice Bolek, Satı Coskun Yazgan, Furkan Ceylan, Jorge Esteban-Villarrubia, Cagatay Arslan, Tülay Kuş, Deniz Tural, Mehmet Ali Nahit Sendur, Nuriye Ozlem Kucuk, Elif Çıngı Özdemir, Elena Castro, Emre Yekedüz and Yüksel Ürün

Hatice Bölek: Does treatment sequencing with cabazitaxel and 177Lu-PSMA-617 impact outcomes in mCRPC?

For more updates, follow OncoDaily.

cabazitaxel cancer Furkan Ceylan Hatice Bölek Jorge Esteban-Villarrubia mCRPC OncoDaily Oncology Satı Coskun Yazgan
Special Coverage
Science
Jan 10, 2025, 19:44
Hatice Bölek: Does treatment sequencing with cabazitaxel and 177Lu-PSMA-617 impact outcomes in mCRPC?
Blog
Jan 10, 2025, 19:29
Treatment of Pleural Mesothelioma: ASCO Guideline Update by Hedy L. Kindler et al.
Blog
Jan 10, 2025, 19:16
Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond - SPCC
Insight
Jan 10, 2025, 18:54
Toufic Kachaamy: An exciting session on Pancreatic Endoscopic Ablation by ASGE
Opinion
Jan 10, 2025, 18:33
5 Articles in Immunotherapy suggested by Wafik El-Deiry
Blog
Jan 10, 2025, 18:28
In Memory of Petra Feyer: A Leader in Oncological Supportive Care
Insight
Jan 10, 2025, 18:23
Nimbus Therapeutics Announced Key Clinical and Business Updates in Oncology Pipeline
Science
Jan 10, 2025, 18:15
Fiber Consumption Linked to Epigenetic Changes with Potential Anti-Cancer Effects
Insight
Jan 10, 2025, 18:08
OneOncology’ Oncology Quality Hub has been Approved by CMS as a Qualified Clinical Data Registry
Insight
Jan 10, 2025, 17:52
UCLA Study Reveals Endocan as a Key Target to Combat Glioblastoma's Growth and Therapy Resistance
Blog
Jan 10, 2025, 17:40
Supriya Peshin: Palliative Medicine Consultation Reduces Readmission Significantly in Certain Diagnoses
Insight
Jan 10, 2025, 17:38
Penilla Gunther: Proud to present another international conference by FOKUS Patient